HRTX Disposition Disclosure
Collard Craig A · SEC Form 4 · Filed Nov 3, 2026
Disposition
Calculated transaction value
$2.37K
Collard Craig A Chief Executive Officer
HRTX
Heron Therapeutics
HRTX
Transaction date
Oct 31, 2026
Public filing date
Nov 3, 2026
Filing lag
Filed 3 days later
HRTX daily price context
Close on/before transaction
$0.28
Oct 30, 2026
First close after public filing
$0.28
Nov 3, 2026
Return after filing · so far
+2.92%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 8,471 shares @ $0.28
- SEC ownership
- Direct
- Transaction code
- F
- Form
- 4
- Filing identifier
- 0001193125-26-444851
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$5.78K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Heron Therapeutics, Inc. /de/ HRTX | Exercise | Oct 31, 2026 | Not reported |
| Heron Therapeutics, Inc. /de/ HRTX | Exercise | Oct 31, 2026 | $0 |
| Heron Therapeutics, Inc. /de/ HRTX Current | Disposition | Oct 31, 2026 | $2.37K |
| Heron Therapeutics, Inc. /de/ HRTX | Exercise | Oct 30, 2026 | $0 |
| Heron Therapeutics, Inc. /de/ HRTX | Exercise | Oct 30, 2026 | Not reported |
| Heron Therapeutics, Inc. /de/ HRTX | Disposition | Oct 30, 2026 | $3.41K |